Logos Global Management LP 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-18 5:04 pm Purchase | 2022-03-08 | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 265,000 6.900% | 115,000 (+76.67%) | Filing |
| 2022-02-15 08:37 am Sale | 2021-12-31 | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 150,000 4.600% | -33,000 (-18.03%) | Filing |
| 2021-12-27 5:25 pm Purchase | 2021-12-17 | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 183,000 5.600% | 183,000 (New Position) | Filing |